Luc Truyen
Chief Tech/Sci/R&D Officer at ARGENX SE
Net worth: 644 878 $ as of 2024-03-30
Profile
Dr. Luc Truyen is a Chief Medical Officer at argenx SE.
Dr. Truyen was previously employed as a Chief Marketing Officer & Head-R&D by Janssen Alzheimer Immunotherapy and a Head-Research & Development by Johnson & Johnson Pharmaceutical Group.
He received his doctorate degree from the University of Antwerp.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ARGEN-X SE
0.00% | 2024-02-19 | 1,631 ( 0.00% ) | 644 878 $ | 2024-03-30 |
Luc Truyen active positions
Companies | Position | Start |
---|---|---|
ARGENX SE | Chief Tech/Sci/R&D Officer | 2022-03-31 |
Former positions of Luc Truyen
Companies | Position | End |
---|---|---|
Johnson & Johnson Pharmaceutical Group | Chief Tech/Sci/R&D Officer | - |
Janssen Alzheimer Immunotherapy | Sales & Marketing | - |
Training of Luc Truyen
University of Antwerp | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ARGENX SE | Health Technology |
Private companies | 2 |
---|---|
Johnson & Johnson Pharmaceutical Group | |
Janssen Alzheimer Immunotherapy |
- Stock Market
- Insiders
- Luc Truyen